Search Results 631-640 of 16555 for Conduction

  1. Heart Valve Disease Clinical Trials - Mayo Clinic Research

    Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 Rochester, MN. The purpose of this study is to establish the safety of using Cara™ Monitor used in TAVR ...

  2. Creative Commons creativecommons licenses.

  3. Mayo Clinic Q & A - Dr. Christopher DeSimone - Atrial Fibril...

    which coordinate electrical conduction with mechanical contraction of the heart. So, in. D. D. D. D. Mayo Clinic Q & A - Dr. Christopher DeSimonPage 2 of 8.

  4. Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation - Mayo Clinic

    ... conduction abnormalities (including prolonged QTc > 500 msec) or abnormal blood pressure at screening except minor deviations deemed to be of no clinical ...

  5. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  6. Neurology - Clinical trials - Mayo Clinic

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  7. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

    Any clinically important abnormalities in rhythm, conduction or morphology of resting ECG (e.g., complete left bundle branch block, third degree heart block); ...

  8. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  9. Anesthesiology and Perioperative Medicine - Clinical trials

    Mayo Clinic's Department of Anesthesiology sees more than 145000 patients each year and integrates patient care, research and education, resulting in ...

  10. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

    Any clinically important abnormalities in rhythm, conduction or morphology of resting ECGs; e.g., complete left bundle branch block, third degree heart block, ...